Merus NV gained accelerated U.S. FDA approval of Bizengri (zenocutuzumab) as the first and only targeted therapy indicated for NRG1-positive pancreatic adenocarcinoma and non-small-cell lung cancer ...

Our immune cells are not just “defenders” against deadly viruses and pathogens but also a great balancer for tissue ...

A ketone body, a molecule derived from the metabolism of acids to obtain energy when glucose is not available, could become ...